Stock solutions of
gentamicin (ITW Reagents, Monza, Italy) were prepared at 4760 µg/mL,
clindamycin (Cayman Chemical, Michigan, MI, USA) at 660 µg/mL, and
vancomycin (ITW Reagents, Monza, Italy) at 1062 µg/mL, according to the manufacturer’s specifications, and kept at −80 °C. Antibiotic working solutions were used at their minimum inhibitory concentration (MIC) values (
gentamicin, 0.238 µg/mL;
clindamycin, 0.033 µg/mL; and
vancomycin, 0.531 µg/mL), as determined in a previous study [65 (
link)].
Nisin A (1000 UI/mg, 2.5% purity) (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 0.02 M HCl (Merck, Darmstadt, Germany), yielding a 1000 µg/mL stock solution, and pexiganan (>95% purity; Innovagen, Lund, Sweden) was dissolved in deionized sterile water, yielding a 2048 µg/mL stock solution. These solutions were then filtered through a
0.22 µm filter (Millipore Corporation, Billerica, MA, USA) and kept at 4 °C. To prepare the dual-AMP biogel, a pexiganan solution at 256 µg/mL was enriched with
Nisin At 125 µg/mL, corresponding to their minimum biofilm eradication concentration (MBEC) values, as determined previously [25 (
link)]. 0.75 g of
guar gum (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 50 mL of sterile distilled water, yielding a 1.5% (
w/
v) gel, which was sterilized by autoclave. Antibiotics and AMPs were mixed into the gel in a 1:1 ratio.
Soares R.S., Gomes D., Serrano I., Cunha E., Tavares L, & Oliveira M. (2023). Absence of Synergism between a Dual-AMP Biogel and Antibiotics Used as Therapeutic Agents for Diabetic Foot Infections. International Journal of Molecular Sciences, 25(1), 407.